Latest Nasdaq Listing News

5E Advanced Materials has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift in its market presence.

American Tungsten & Antimony Ltd (ASX: AT4) has raised A$10 million through a strongly supported placement and secured a 40% Utah state tax credit, underpinning its strategy to develop a domestic US supply chain for tungsten and antimony ahead of a planned Nasdaq listing.

Jindalee Lithium has launched a non-renounceable entitlement offer priced at A$0.46 per share, including attaching options exercisable at A$0.60, aiming to raise capital by early June 2026.

Red Mountain Mining has gained NSW Resources Regulator approval for a 32-hole reverse circulation drilling program at its Oaky Creek Antimony-Gold Project, targeting a significant 3km strike of orogenic mineralisation. An orientation Induced Polarisation survey has been completed to refine drill targeting, with results expected soon.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Jindalee Lithium has locked in a strongly supported A$11 million capital raise through a placement and entitlement offer to fund its McDermitt Lithium Project and the proposed NASDAQ listing of US Elemental Inc.

European Lithium (ASX: EUR) has affirmed its compliance with ASX continuous disclosure rules following its announcement of a non-binding merger proposal with Critical Metals Corp. (CRML). The company detailed its negotiation timeline and rationale for the timing of its market disclosures.

Chilwa Minerals confirmed a significant niobium discovery at its Nakombe target, progressing with dual diamond rig drilling and advancing a NASDAQ listing application. Heavy mineral sands resource work continues alongside a new ionic clay rare earth program.

Resolution Minerals has successfully produced high-grade tungsten concentrates from historical stockpiles at its Golden Gate mine, achieving a 19-fold upgrade and strong recovery rates using simple gravity separation techniques.

American Tungsten & Antimony (ASX: AT4) has set up a Level 1 ADR program with Deutsche Bank, paving the way for its planned Nasdaq listing in Q2 2026 and opening U.S. dollar trading access for American investors.

American Rare Earths is fast-tracking its Wyoming Halleck Creek rare earths project, defining a pilot plant pathway, advancing oxide to metal studies, and targeting a NASDAQ listing by year-end 2026.

CLINUVEL Pharmaceuticals has received final scientific advice from the European Medicines Agency on the design of its pivotal Phase III trial for SCENESSE in vitiligo, endorsing a comprehensive evidence approach and prioritising patients with darker skin tones.